Searchable abstracts of presentations at key conferences in endocrinology

ISSN 1470-3947 (print) | ISSN 1479-6848 (online)

Endocrine Abstracts

Published by BioScientifica

Previous issue | Volume 99 | ECE2024 | Next issue

26th European Congress of Endocrinology

Stockholm, Sweden
11 May 2024 - 14 May 2024

We are pleased to announce that ECE 2024 will be held in Stockholm, Sweden from 11-14 May 2024. We will, once again, be offering the hybrid format next year so you can join us in person in Sweden or remotely with ECE@Home.

Poster Presentations

Endocrine-Related Cancer

Previous section
Diabetes, Obesity, Metabolism and Nutrition

Table of contents

Next section
Environmental Endocrinology

ea0099p88 | Endocrine-Related Cancer

The BRAF K601E mutation in thyroid tumors: One alteration with a dual clinical significance

ea0099p89 | Endocrine-Related Cancer

Effectiveness of temozolomide treatment in SDHx mutant and wildtype metastatic pheochromocytoma and paraganglioma – results of a European restrospective multicentre study

ea0099p90 | Endocrine-Related Cancer

Does mitotane offer lasting cure or transitory benefits following adrenocortical carcinoma surgery?

ea0099p91 | Endocrine-Related Cancer

Clinical impact and genetic alterations in the DAXX gene in patients with neuroendocrine tumors of the gastroenteropancreatic system and the lung

ea0099p92 | Endocrine-Related Cancer

How well does ‘real world’ management of Immune check point inhibitor induced hypophysits (ICI-Hp) reflect the European Society of Endocrinology (ESE) 2023 clinical practice guidelines (CPG)?: Experience from a single tertiary care centre

ea0099p93 | Endocrine-Related Cancer

Risk of differentiated thyroid cancer among Danish women with polycystic ovary syndrome

ea0099p94 | Endocrine-Related Cancer

Cervico-mediastinal hematoma: Atypical presentation of parathyroid carcinoma associated to hashimoto thyroiditis

ea0099p95 | Endocrine-Related Cancer

Do immune checkpoint inhibitor-related endocrinopathies affect survival rates in cancer patients? Presentation of two case reports

ea0099p96 | Endocrine-Related Cancer

Increased calcitonin level in cases with multinodular goitre and ectopic Cushing syndrome – diagnostic challenges

ea0099p97 | Endocrine-Related Cancer

Spontaneous and treatment-related changes in calcitonin doubling rate of medullary thyroid cancer. Long-term experience in a patient with multiple endocrine neoplasia type 2B

ea0099p98 | Endocrine-Related Cancer

Targeting focal adhesion kinase (FAK) and spleen tyrosine kinase (SYK) in gastrointestinal neuroendocrine tumors: Unveiling mechanisms and anti-proliferative effects

ea0099p99 | Endocrine-Related Cancer

Metastatic paragangliomas – real world data in a single tertiary center

ea0099p100 | Endocrine-Related Cancer

Incidentaloma on Ga-68-DOTANOC PET; prevalence and clinical significance

ea0099p209 | Endocrine-Related Cancer

Comparison of existing guidelines on the perceived endocrine symptoms of breast cancer patients – preliminary results

ea0099p210 | Endocrine-Related Cancer

The lived experience of people with adrenocortical carcinoma

ea0099p213 | Endocrine-Related Cancer

Endocrine autoimmunity during immunotherapy for cancer – a snapshot from an Oncologic Institute in Romania

ea0099p300 | Endocrine-Related Cancer

An apparently non-functional retroperitoneal SDHB-related paraganglioma

ea0099p301 | Endocrine-Related Cancer

Dual targeting Boolean logic gate CAR-T cells for selective tumor antigen encounter exert potent antitumor efficacy in advanced adrenocortical carcinoma

ea0099p302 | Endocrine-Related Cancer

Alteration in the molecular components of machinery that regulate gene expression mechanisms and genomic stability in thyroid cancer and their association with tumour behaviour and/or clinical features

ea0099p303 | Endocrine-Related Cancer

Clinical characteristics and survival of patients with functional pancreatic neuroendocrine tumors

ea0099p304 | Endocrine-Related Cancer

Basal calcitonin and calcium gluconate test in suspect medullary thyroid carcinoma: Are we expecting too much from stimulated calcitonin?

ea0099p305 | Endocrine-Related Cancer

Cell cycle regulation in parathyroid adenomas and multiglandular parathyroid disease: Similarities, differences and heterogeneity

ea0099p306 | Endocrine-Related Cancer

Long-acting starch (Glycosade(R)): An effective treatment for insulinoma-induced hypoglycemia – A case report

ea0099p307 | Endocrine-Related Cancer

The intrinsically disordered activation function 1 of Progesterone receptor is involved in the dynamics of the receptor complex

ea0099p308 | Endocrine-Related Cancer

Possible prognostic role of BMI before chemotherapy in the outcomes of women with ovarian cancer

ea0099p309 | Endocrine-Related Cancer

Cystic mediastinal lesions as presenting manifestation of papillary thyroid cancer

ea0099p310 | Endocrine-Related Cancer

Immunohistochemical profiling of HIF-2α and SSTR2 with the tumor microenvironment in metastatic pheochromocytoma and paraganglioma

ea0099p311 | Endocrine-Related Cancer

The impact of primary tumor site on clinical manifestation and prognosis of ectopic Cushing’s syndrome (ECS). Do pulmonary neuroendocrine tumors stand out?

ea0099p498 | Endocrine-Related Cancer

Once-daily oral paltusotine in the treatment of patients with carcinoid syndrome: interim results from a phase 2, randomized, parallel-group study

ea0099p499 | Endocrine-Related Cancer

Early detection of recurrence and progress using serum steroid profiling by LC–MS/MS in patients with adrenocortical carcinoma

ea0099p500 | Endocrine-Related Cancer

Catching the silent culprits: Prospective TERT promoter mutation screening for minimally invasive follicular and oncocytic thyroid carcinoma in clinical practice

ea0099p501 | Endocrine-Related Cancer

Clinical features and outcome in patients with functional head and neck paragangliomas: French national cohort and literature review

ea0099p502 | Endocrine-Related Cancer

Ovarian neuroendocrine tumor metastases can induce estrogen production in postmenopausal patients

ea0099p503 | Endocrine-Related Cancer

Presurgical lactate dehydrogenase (LDH) levels: A risk factor for disease progression in operated adrenocortical carcinomas

ea0099p504 | Endocrine-Related Cancer

Advanced ACC stage: Therapeutic approach and biological findings

ea0099p505 | Endocrine-Related Cancer

Growth differentiation factor 15 (GDF-15) is induced by mitotane in adrenocortical carcinoma and associated with poor prognosis and impaired responsiveness to immunotherapy

ea0099p506 | Endocrine-Related Cancer

Primary hyperparathyroidism due to parathyroid cancer or atypical adenoma. a third-level spanish hospital experience

ea0099p507 | Endocrine-Related Cancer

SRSF6 modulates histone-chaperone HIRA splicing to orchestrate androgen and E2F signalling in prostate cancer

ea0099p508 | Endocrine-Related Cancer

Adrenal tumors in children and adolescents in Sweden: A diagnosis related groups-based analysis from 2005–2019

ea0099p509 | Endocrine-Related Cancer

Variants of genes that reduce the function of the progesterone receptor, vitamin D receptor, and 1α-hydroxylase enzyme are associated with an earlier onset of breast cancer

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

Biosci Abstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more